Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -24.67%16.23M | 13.75M | 41.49%121.22M | -25.92%15.29M | 17.54%20.26M | -9.07%85.68M | 20.64M | 24.24%21.41M | 21.54M | 40.70%22.09M |
| Cost of revenue | -22.47%6.72M | 6.16M | 46.62%49.41M | -4.42%7.53M | 38.85%8.18M | -13.17%33.7M | 7.88M | 40.36%8.27M | 8.67M | 47.45%8.88M |
| Gross profit | -26.16%9.5M | 7.59M | 38.16%71.81M | -39.21%7.76M | 6.47%12.08M | -6.20%51.98M | 12.76M | 15.87%13.14M | 12.87M | 36.49%13.2M |
| Operating expense | -19.32%10.36M | 8.74M | 42.14%74.09M | -22.02%10.11M | 5.52%11.8M | -1.32%52.12M | 12.97M | 26.52%14.15M | 12.84M | 18.91%12.17M |
| Other operating expenses | -22.54%12.17M | --10.45M | 43.55%83.24M | -17.87%11.6M | 3.59%13.16M | -5.34%57.99M | --14.13M | 18.60%15.06M | --15.72M | 25.93%13.08M |
| Total other operating income | -36.86%1.82M | --1.71M | 56.05%9.15M | 28.58%1.49M | -10.61%1.36M | -30.51%5.87M | --1.16M | -39.82%913K | --2.88M | 489.68%914K |
| Operating profit | -2,534.29%-852K | -1.15M | -1,440.54%-2.28M | -1,017.06%-2.36M | 73.58%276K | -105.71%-148K | -211K | -733.33%-1.01M | 35K | 284.82%1.04M |
| Net non-operating interest income (expenses) | 58.18%-289K | -355K | -30.10%-3.93M | 66.49%-247K | -52.38%-704K | 7.93%-3.02M | -737K | -73.38%-801K | -691K | -20.58%-791K |
| Non-operating interest income | -93.28%8K | --11K | 45.60%463K | -1.10%90K | 96.43%55K | --318K | --91K | 103.57%57K | --119K | -66.67%51K |
| Non-operating interest expense | -63.33%297K | --366K | 17.71%3.93M | -59.30%337K | 54.90%759K | 1.77%3.34M | --828K | 75.10%858K | --810K | 4.08%842K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 541.96%1.9M | -3.19M | -122.59%-2.72M | -114.56%-233K | 51.33%-1.27M | 85.43%-1.22M | 1.6M | 73.37%-692K | -429K | 66.86%-1.7M |
| Income from associates and other participating interests | 195.85%2.24M | -6.05M | -130.84%-9.15M | -48.00%-2.19M | -237.45%-2.41M | 5.69%-3.96M | -1.48M | 101.12%8K | -2.34M | 95.74%-159K |
| Special income (charges) | -29.73%1.23M | -1.16M | 25.81%12.36M | -149.54%-1.58M | -49.26%3.52M | 206.48%9.83M | 3.19M | -130.32%-2.1M | 1.75M | 7M |
| Less:Other special charges | ---- | ---- | ---70K | ---- | 98.51%-70K | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | 29.73%-1.23M | --1.16M | -25.10%-12.29M | 149.54%1.58M | -55.03%-3.45M | -190.21%-9.83M | ---3.19M | 194.52%2.1M | ---1.75M | ---7M |
| Less:Negative goodwill immediately recognized | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 352.09%4.22M | -11.9M | -488.32%-5.72M | -379.70%-6.6M | -117.39%-578K | 106.54%1.47M | 2.36M | -238.27%-4.6M | -1.67M | 153.37%5.38M |
| Income tax | 107.14%551K | 193K | 8.49%3.44M | -101.68%-33K | 2.03%302K | -10.60%3.17M | 1.96M | -33.45%197K | 266K | 8.76%745K |
| Net income | 289.12%3.67M | -12.09M | -439.16%-9.16M | -1,750.25%-6.57M | -129.06%-880K | 93.48%-1.7M | 398K | -258.29%-4.79M | -1.94M | 143.05%4.64M |
| Net income continuous operations | 289.12%3.67M | ---12.09M | -439.16%-9.16M | -1,750.25%-6.57M | -129.06%-880K | 93.48%-1.7M | --398K | -258.29%-4.79M | ---1.94M | 143.05%4.64M |
| Noncontrolling interests | -501.32%-908K | -569K | -306.35%-256K | -9,675.00%-383K | -61.44%59K | 96.66%-63K | 4K | -239.22%-213K | -151K | -60.24%297K |
| Net income attributable to the company | 355.84%4.58M | -11.52M | -444.28%-8.9M | -1,669.80%-6.19M | -132.66%-939K | 93.23%-1.64M | 394K | -259.30%-4.58M | -1.79M | 137.68%4.34M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 355.84%4.58M | -11.52M | -444.28%-8.9M | -1,669.80%-6.19M | -132.66%-939K | 93.23%-1.64M | 394K | -259.30%-4.58M | -1.79M | 137.68%4.34M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 333.33%0.0007 | -0.0018 | -366.67%-0.0014 | -1,100.00%-0.001 | -120.00%-0.0001 | 92.11%-0.0003 | 0.0001 | -240.00%-0.0007 | -0.0003 | 138.89%0.0007 |
| Diluted earnings per share | 300.00%0.0006 | -0.0018 | -366.67%-0.0014 | -1,100.00%-0.001 | -125.00%-0.0001 | 92.11%-0.0003 | 0.0001 | -275.00%-0.0007 | -0.0003 | 133.33%0.0006 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.